Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer

Danmark Nyheder Nyheder

Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer
Danmark Seneste Nyt,Danmark Overskrifter
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 61 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 51%

A novel antibody-drug conjugate continues to demonstrate superior benefit for patients with HR+, HER2- metastatic breast cancer when compared to standard chemotherapy, according to a new study in The Lancet.

Overall survival in the intention-to-treat population. This is the planned final analysis of overall survival in the intent-to-treat population of all randomly assigned patients. Vertical hash marks indicate censored data.

The sacituzumab group also showed superior response rates as well as prolonged median progression-free survival when compared to standard chemotherapy. Patients treated with sacituzumab had a 34% lower risk of cancer progression or death than those treated with chemotherapy. "These data reinforce that sacituzumab govitecan is leading to improvements in both progression- free and overall survival and that patients saw benefit irrespective of their tumor's Trop-2 expression," says Sara Tolaney, MD, MPH, chief of the Division of Breast Oncology at the Susan F. Smith Center for Women's Cancers at Dana-Farber and the study's senior author.

Earlier data from the TROPICs-02 study that was presented at last year's ASCO annual meeting as well at the European Society for Medical Oncology conference led to the accelerated FDA approval of sacituzumab govitecan for the treatment of metastatic HR+/HER2- breast cancer in February of this year. The first authors of the study are Hope S. Rugo, MD, of the University of California-San Francisco and the Helen Diller Family Comprehensive Cancer Center, and Aditya Bardia, MD, MPH, of Massachusetts General Hospital Cancer Center.

Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere:

medical_xpress /  🏆 101. in UK

Danmark Seneste Nyt, Danmark Overskrifter

Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.

Destiny 2's The Final Shape expansion will add new Arc, Solar and Void supersDestiny 2's The Final Shape expansion will add new Arc, Solar and Void supersBungie blasted out a bunch of new info on what to expect from its big finale and beyond.
Læs mere »

Sonic Superstars gets October release date, Sonic Frontiers' The Final Horizon update out in SeptemberSonic Superstars gets October release date, Sonic Frontiers' The Final Horizon update out in SeptemberSonic the Hedgehog fans now have two more dates for their diaries courtesy of tonight's Gamescom Opening Night Live, wi…
Læs mere »

Barnard ton seals One-Day semi-final spot for BearsBarnard ton seals One-Day semi-final spot for BearsEd Barnard's century secures a One-Day Cup semi-final place for Warwickshire, while Lancashire claim the last quarter-final spot.
Læs mere »

Sonic Frontiers: The Final Horizon update set to bring new story, characters and challengesSonic Frontiers: The Final Horizon update set to bring new story, characters and challengesSonic Frontiers is set to receive a brand-new free 'The Final Horizon' update next month.
Læs mere »

Mageean a brave fourth in World 1500m finalMageean a brave fourth in World 1500m finalIreland's Ciara Mageean just misses out on a medal in the 1500m final at the World Championships after breaking her own national record.
Læs mere »

Pakistan: Crowd welcomes final children rescued from dangling cable carPakistan: Crowd welcomes final children rescued from dangling cable carThe incident started when a cable line snapped as the group was travelling to school. The cable car spans a river and connects villages in a remote mountainous area.
Læs mere »



Render Time: 2025-03-31 18:19:54